Search
for

    Sort by

    Research 28

    1. Tamsulosin and Solifenacin : A Dynamic Duo in BPH Management International Journal of Health and Medicine · 2025
    2. Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study Actas urológicas españolas · 2019
    3. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    4. Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma Journal of endourology case reports · 2019 · 3 citations
    5. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    6. Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis European Journal of Medical Research · 2023
    7. Targeting PrfA from Listeria monocytogenes: a computational drug repurposing approach bioRxiv (Cold Spring Harbor Laboratory) · 2023
    8. Drugs that affect autonomic functions or the extrapyramidal system Side effects of drugs annual · 2009
    9. Green Technologies in the Generic Pharmaceutical Industry 2010 · 10 citations
    10. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia Actas urológicas españolas · 2018
    11. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    12. Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy Archivio Italiano di Urologia e Andrologia · 2024 · 5 citations
    13. STABILITY INDICATING AN LC-ESI-MS/MS METHOD FOR THE QUANTIFICATION OF MINOXIDIL IN PHARMACEUTICAL DOSAGE FORMS International Journal of Applied Pharmaceutics · 2026
    14. Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis International Neurourology Journal · 2025
    15. African Journal of Biomedical Research 2025
    16. Simultaneous Quantification of Dutasteride and Silodosin Using a Stability-Indicating RP-HPLC Approach International Journal of Pharmaceutical Quality Assurance · 2024
    17. A fixed-dose combination of finasteride and tadalafil (Entadfi) for BPH. PubMed · 2022
    18. Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014) Age and Ageing · 2015 · 111 citations
    19. Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis The Scientific World Journal · 2014 · 291 citations
    20. The Pharmacology of Regenerative Medicine Pharmacological Reviews · 2013 · 47 citations
    21. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials 2018 · 21 citations
    22. Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments Clinical Epidemiology · 2022 · 4 citations
    23. The post-finasteride syndrome: possible etiological mechanisms and symptoms International journal of impotence research · 2023 · 3 citations
    24. Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition? Der Urologe · 2019 · 3 citations
    25. Inhibitory effects of the ATP-sensitive potassium channel openers cromakalim, pinacidil and minoxidil on the carbachol–response curve in porcine detrusor muscle Arab Journal of Urology · 2012 · 3 citations
    26. Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men Current Geriatrics Reports · 2019 · 2 citations
    27. Nourishing Hair Oil Research Journal of Pharmaceutical Dosage Forms and Technology · 2023
    28. Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model The Journal of Urology · 2022